Investigational Site Number 840101 — Picayune, Mississippi

Investigational Site Number 840101 is a clinical research site located in Picayune, Mississippi, United States 39466.

Crixeo Clinical Trials Trust Score: 4/100 (FAILING). This profile has not yet been claimed by the site owner.

Investigational Site Number 840101 has participated in 1 clinical trials.

Therapeutic areas: Atrial Fibrillation.

Sponsors: Sanofi.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Picayune

Browse all research sites in Mississippi · View every site in Picayune

• Highland Community Hospital
• GSK Investigational Site
• Novartis Investigative Site
• Pfizer Investigational Site
• Mississippi Medical Research
• Research Site
• Spence Medical Research
• Riser Medical Associates
• 205.479.01041 Boehringer Ingelheim Investigational Site
• Investigator Site
• Local Institution - 0060
• Forest Investigative Site 1271

Sponsor Feasibility Report

Trust Score: 4/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Investigational Site Number 840101?

Investigational Site Number 840101 has a Crixeo Trust Score of 4/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Investigational Site Number 840101 conducted?

Investigational Site Number 840101 has 1 clinical trials on record. Their work covers Atrial Fibrillation.

Is Investigational Site Number 840101 accredited by Crixeo Clinical Trials?

Investigational Site Number 840101 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Investigational Site Number 840101?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.